Risk to bystanders in clinical trials: A symposium

  title={Risk to bystanders in clinical trials: A symposium},
  author={Nir Eyal},
  journal={Clinical Trials},
  pages={447 - 449}
  • N. Eyal
  • Published 1 August 2019
  • Medicine
  • Clinical Trials
This symposium takes a critical look at the ethics of impact on “bystanders” to clinical research. By that we mean study non-participants who nevertheless are at risk of being affected by the study in some way. This introduction suggests some questions to consider while reading through the symposium contributions, and gives a précis of each. 
1 Citations

Topics from this paper

COVID-19 controlled human infection studies: worries about local community impact and demands for local engagement
It is argued that the health effects of CHI studies on local residents not participating in the study tend to be smaller and more positive than those of field trials.


A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection
The results suggest that any future HIV intervention trials would benefit from the inclusion of a placebo arm, and the degree and kinetics of plasma viral rebound after ART interruption have potentially important implications for the design of future interventions aimed at achieving ART-free control of HIV infection.
Ethics of maternal vaccination
An ethical approach focused on mothers' primary interests in protecting themselves and their children could serve as the basis of the ethical framework that guides vaccine policies.
Interrupting antiretroviral treatment in HIV cure research: scientific and ethical considerations
Ethical standards for HIV cure research involving ATIs are outlined and basic ethical criteria can be met with careful study design and close monitoring.
Ethics of Internet research trigger scrutiny
Research toward a cure trials. Treatment Action Group
  • http://www.treatmentactiongroup.org/cure/trials
  • 2018
  • 2017
  • Science
  • 2016
Research toward a cure trials